The Renal Drug Handbook: The Ultimate Prescribing Guide for Renal Practitioners, 5th Edition

Product Information

Saher T, Al-Worafi YM, Iqbal MN, Wahid A, Iqbal Q, Khan A, et al. Doctors’ adherence to guidelines recommendations and glycaemic control in diabetic patients in Quetta, Pakistan: findings from an observational study. Front Med. 2022;9:978345–5. Saleem A, Masood I. Pattern and predictors of medication dosing errors in chronic kidney disease patients in Pakistan: a single center retrospective analysis. PLoS ONE. 2016;11(7):e0158677. Pharmaceutical Preformulation and Formulation: a Practical Guide from Candidate Drug Selection to Commercial Dosage Form - 2nd ed. (2009) Sheen SS, Choi JE, Park RW, Kim EY, Lee YH, Kang UG. Overdose rate of drugs requiring renal dose adjustment: data analysis of 4 years prescriptions at a tertiary teaching hospital. J Gen Intern Med. 2008;23:423–8. Neerkin J, Brennan M, Jamal H. Use of opioids in patients with impaired renal function. In.: Nottingham, Engl: Palliativedrugs. com;2012.

Ahmad N, Hassan Y, Tangiisuran B, Meng OL, Aziz NA, Khan AH. Guidelines adherence and hypertension control in an outpatient cardiology clinic in Malaysia. Trop J Pharm Res. 2012;11(4):665–72. Kidny Disease Improving Global Outcomes. Blood pressure guideline. 2021; Available at: https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2021-BP-GL.pdf. Accessed 10 November 2022. Alahdal AM, Elberry AA. Evaluation of applying drug dose adjustment by physicians in patients with renal impairment. Saudi Pharm J. 2012;20(3):217–20.

The ultimate prescribing guide for renal practitioners

Getachew H, Tadesse Y, Shibeshi W. Drug dosage adjustment in hospitalized patients with renal impairment at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia. BMC Nephrol. 2015;16(1):1–9. This is a much-needed reference with good and precise explanations of relevant drugs. One of the noteworthy aspects is that the authors have tried their best to translate the important information into a concise but effective format. The authors must be applauded for maintaining the uniform presentation structure for each drug monograph. Overall, this is an excellent handbook for anybody who wants to learn about drugs at a glance or wishes a quality reference for prescribing for those with renal impairment." Lameire NH, Levin A, Kellum JA, Cheung M, Jadoul M, Winkelmayer WC et al. Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 2021;100(3):516–526. Blood Results in Clinical Practice: A Practical Guide to Interpreting Blood Test Results - 2nd ed. (2019)

Biologics, Biosimilars and Biobetters: An Introduction for Pharmacists, Physicians and other Health Practitioners(2021) Rossing P, Caramori ML, Chan JC, Heerspink HJ, Hurst C, Khunti K, et al. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2022;102(5):1–S127. Gulalai, Ahmad N, Wahid A, Khan A, Atif M, Khan A. Evaluation of management and factors associated with hypertension control in hemodialysis patients at a tertiary-care hospital in Pakistan. Drugs Ther Perspect. 2020;36(9):396–403.This is a much-needed reference with good and precise explanations of relevant drugs. One of the noteworthy aspects is that the authors have tried their best to translate the important information into a concise but effective format. The authors must be applauded for maintaining the uniform presentation structure for each drug monograph. Overall, this is an excellent handbook for anybody who wants to learn about drugs at a glance or wishes a quality reference for prescribing for those with renal impairment.